Product Images Adbry
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 16 images provide visual information about the product associated with Adbry NDC 50222-346 by Leo Pharma Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Figure A - tralokinumab 01
This text provides instructions for the use of a medical syringe. It mentions the use of a needle guard and the importance of checking the expiration date on the label. It also instructs the user to administer two separate injections using pre-filled syringes to receive a full dose. There is no mention of the specific medication or condition being treated.*
Figure B - tralokinumab 02
ADBRY prefilled syringes are medical devices designed for the administration of medication through injection. The text only provides the name of the product and does not provide any further useful description.*
Figure C - tralokinumab 03
Figure D - tralokinumab 04
Figure E - tralokinumab 05
Figure F - tralokinumab 06
Figure G - tralokinumab 07
This text suggests that a certain injection can only be administered by a caregiver and not by the individual receiving the injection. The letter "B" preceding "Selfinjection or by caregiver" may indicate that there is an option for self-injection, but further information is needed to confirm this.*
Figure H - tralokinumab 08
Figure I - tralokinumab 09
Figure J - tralokinumab 10
Figure K - tralokinumab 11
Figure L - tralokinumab 12
Figure M - tralokinumab 13
Figure N - tralokinumab 14
PRINCIPAL DISPLAY PANEL - 150 mg/mL Syringe Carton - NDC 50222-346-02 - tralokinumab 15
This is a description of a medication called "T". It is in the form of an injection and comes in two syringes. Each syringe contains 150 mg/mL of the medication. The medication is intended for subcutaneous use only. The carton contains two single-dose prefilled syringes with needle guard. The medication must be stored refrigerated between 2°C to 8°C and protected from light. Additional instructions for use and patient information are available in the package.*
PRINCIPAL DISPLAY PANEL - 150 mg/mL Syringe Carton - NDC 50222-346-04 - tralokinumab 16
Description: Adbry is a drug that comes in the form of an injection with a concentration of 150mg/mL per syringe. It is only for subcutaneous use and is packaged in a multi-pack of four 2mL single-dose prefilled syringes, which provide a total of 800mg. The drug should be stored between 2°C to 8°C, and the original carton should be used to protect it from light.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.